Cipla Medpro buyout offer divides shareholders – Cardiology News

State tenders are becoming a major source of revenue for local drugs firm Cipla Medpro South Africa (CMSA). The group almost doubled its state business from R372-m to R693-m in the year to December and it expects this to rise to R1-bn in the current financial year. view article

Noncore asset chop? – Financial Mail

BHP Billiton’s aluminium and manganese operations in SA are likely to be next on the block as the group’s new CEO streamlines the portfolio. view article

invest
now